Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

March 31, 2004

Study Completion Date

July 31, 2007

Conditions
Lung Cancer
Interventions
DRUG

vinorelbine tartrate

Trial Locations (13)

55416

CCOP - Metro-Minnesota, Saint Louis Park

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00008333 - Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter